("about right") was physiotherapy 67%, exercise 37%, enzymes 78%, and vitamins 9%. Compliance was not influenced by demographic details nor by severity of disease, although patients producing large amounts of sputum and receiving help with physiotherapy were more compliant with physiotherapy. The physiotherapist and physician judged correctly the degree of compliance with physiotherapy in 83% and 75% of cases, respectively, and with exercise in 68% and 67% of cases, respectively. Conclusions -The reported degree of compliance and reasons for poor compliance were treatment specific. Demographic and disease severity variables were not associated with compliance. Those involved in the care of patients with cystic fibrosis were able to predict patient compliance. (Thorax 1994;49:115-120) 
recorded before completion of the questionnaire. The questionnaire, administered by a psychologist, assessed the reported degree of patient compliance, their perception of compliance, and their reasons for poor compliance.
Results -Sixty patients participated in the study and 51/60 and 41/55 patients were considered compliant with enzyme and exercise therapies, respectively. Compliance was lower with physiotherapy (32/60) and vitamin treatment (21/ 45). Patients reporting immediate benefits following exercise and physiotherapy were more compliant than those reporting no improvement. The perception by patients that compliance was sufficient ("about right") was physiotherapy 67%, exercise 37%, enzymes 78%, and vitamins 9%. Compliance was not influenced by demographic details nor by severity of disease, although patients producing large amounts of sputum and receiving help with physiotherapy were more compliant with physiotherapy. The physiotherapist and physician judged correctly the degree of compliance with physiotherapy in 83% and 75% of cases, respectively, and with exercise in 68% and 67% of cases, respectively. Conclusions -The reported degree of compliance and reasons for poor compliance were treatment specific. Demographic and disease severity variables were not associated with compliance. Those involved in the care of patients with cystic fibrosis were able to predict patient compliance. (Thorax 1994; 49:115-120) An increasing number of patients with cystic fibrosis are surviving into adulthood; this has been attributed to earlier diagnosis, specialist care, and more effective methods of treatment."4 Compliance, defined as the degree of patient adherence to medical advice and treatment regimens, may be an important factor in the successful management of the disease.
The daily management includes physiotherapy, exercise, oral and inhaled medication for the respiratory system, and oral pancreatic enzymes and vitamin supplements for the control of malabsorption. Those patients awaiting heart-lung transplantation may additionally need to manage home gastrostomy feeding and nocturnal ventilation. A complex and time consuming regimen of self care is therefore expected of the patient.
There is no conclusive link between poor compliance with treatment and progressive disease in cystic fibrosis. However, non-compliance with treatment and medical advice may cause accelerated disease, wasted resources, increased outpatient visits, and more admissions to hospital, and the ability to predict the effectiveness of treatment may be impaired.
Previous studies of compliance have concentrated on children using parental reporting, or have been confounded by combining the results of children and adults.7 Little attention has been given to adults who are often striving for independence with their management regimens. In addition, these studies have suffered from poor experimental design, with data obtained whilst in hospital or from medical records, and use of insensitive scoring systems. Most have assessed several treatment regimens but have combined the data to provide an overall score, thereby losing specific treatment data.7-' An overall compliance score fails to recognise that patients may comply, to varying degrees, with different components of a treatment regimen. In a study of adult patients with cystic fibrosis 76% took their prescribed drugs 90% of the time, while only 54% of patients adhered to their physiotherapy regimens and 57% to their exercise regimens.10
In order to improve compliance, factors which predict compliance need to be identified, together with the reasons for poor adherence. This study aimed to investigate these areas in adults with cystic fibrosis.
Methods

SUBJECTS
Consecutive patients attending the Monsall Adult Cystic Fibrosis Unit were invited to take part in the study. It was intended to recruit half the patients attending the unit, and 67 patients were approached.
INTERVIEW
Each patient was interviewed during a period of clinical stability by a psychologist and guided through the compliance questionnaire (see appendix on page 120). The accuracy of the interview was validated by asking a close companion (usually mother or partner) questions phrased in a similar manner about the patient's degree of compliance. To minimise the "faking of good effect" by patients, interviews were conducted away from the wards or treatment areas by those not directly involved in patient treatment. The questionnaire also included general questions for some treatments -for example -"do you have help with your physiotherapy," "do you feel better following physiotherapy and exercise," "are you prescribed vitamins?"
The timing of pancreatic enzyme administration during meals was also ascertained (appendix).
Measures of patient perception of compliance For each treatment modality patients were asked to choose from one of four statements: "about right," "not enough," "too much," and "don't know" (questions 7, 12, 18, and 24, appendix).
Measures of patient reasons for poor compliance Patients selected their reasons for poor compliance from a list for each of the four treatments (appendix). They were also encouraged to add other reasons of their choice.
Self prescribed medication Details of frequency and type of self prescribed medication were collected (questions 25-27, appendix).
DEMOGRAPHIC DATA Medical history Details of age, sex, employment status, and age at diagnosis were obtained from medical records. The number of clinic visits in the previous year and contact with carers for inpatient and outpatient treatment was compared. The number of years of practising physiotherapy and any help received with physiotherapy were validated by patients' responses to the questionnaire.
Clinical measures At the time the questionnaire was administered each patient was seen by two physicians to obtain a Shwachman score. Measurements were made of respiratory function (FEV, % predicted and FVC % predicted) and 24 hour sputum weight (> 35 g/day = large volume sputum producer, < 35 g/day = small volume sputum producer).
PREDICTORS OF COMPLIANCE
A predicted degree of compliance with physiotherapy and exercise was made independently by the physiotherapist and physician on a similar scale to that completed by the patient. Enzymes (n= 60) 47 (78) 5 (8) 2 (4) 6 (10) Vitamins (n=45) 4 (9) 19 (42) 1 (2) 21 (47) Values in parentheses are percentages. 6 Physicians have previously been reported to be poor at recognising patients who are compliant or non-compliant with the taking of medication,'6 17 although a director of a paediatric cystic fibrosis clinic correctly identified requirements for antibiotic treatment in 80% of cases.5 In this study both the physician and the physiotherapist differentiated between compliant and non-compliant patients for exercise and physiotherapy in most cases. Accurate predictions of compliance made by those involved in care of the patients probably results from a high level of continuing medical care and lifelong informal contact with the patient and family. This ability to predict compliance did not influence the level of adherence by patients, but it may assist the carers in assessing efficacy of treatment.
It may be unrealistic to expect young adults with cystic fibrosis to follow absolutely treatment advice as they attempt to strike a balance between their needs and the daily time consuming treatment regimens. This study found no associations between demographic or clinical variables and compliance with treatment. Severity of disease and the long term benefits of treatment regimens may not ensure compliance if the patient does not share the perceptions of the carers.
Compliance may be improved by offering patients the choice of treatments they prefer. We have previously shown that, when patients are given a choice between physiotherapy alone, exercise alone or the two combined, two thirds preferred the latter option. '8 A crucial time when compliance needs to be enhanced is when patients are transferring from paediatric to adult care. Although patient independence and self involvement are encouraged, the interest and support from family and partners are crucial. I have difficulty swallowing them.
I have difficulty getting repeat prescriptions.
: I simply forget. L My body occasionally needs a rest from medication, otherwise I may become immune to them, and they will not work when I really need them.
C -I only take enzymes when I feel unwell.
[X I resent having to take them. I don't want my friends colleagues to know that I have CF.
I don't fully understand why I need to take them.
My CF isn't as serious as most of the other CF patients. I have too many different treatments to attend to, and this is the least important of them.
I don't believe that they do me any good.
LI I can't always be bothered.
El They make me feel worse. Tick as many boxes as you like I only take them when they are given to me.
I don't like the taste. I have difficulty swallowing them. I take more than has been prescribed for me. I have difficulty getting repeat prescriptions. They make me feel worse. I simply forget. My body occasionally needs a rest from medication, otherwise I may become immune to them, and they will not work when I really need them. I I only take vitamins when I feel unwell.
I resent having to take them. I don't want my friends colleagues to know that I have CF. El I don't fully understand why I need to take them.
My CF isn't as serious as most of the other CF patients.
I have too many different treatments to attend to, and this is the least important of them. I don't believe that they do me any good. 
